Closing the oversubscribed 1.2 M€ seed round with an investment from ENEA Tech e Biomedical

We are proud to announce that Recornea has successfully secured over 1.2 M€ in financing as part of our oversubscribed Seed round

We are proud to announce that Recornea has successfully secured over 1.2 M€ in financing as part of our oversubscribed Seed round, led by our visionary new investor ENEA Tech e Biomedical, a private foundation supervised by the Ministry of Business and Made in Italy based in Rome, together with the new investors BHeroes, Caique Holding, DN Lemans and Scientifica along with the existing investor Health Wildcatters with their follow-on investment. Thanks to our incredible - extended - team of highly committed professionals, experts, advisors and forward-thinking investors (both existing and new) for believing in our mission of preventing blindness through innovation exploiting minimally invasive super-elastic nitinol solutions.